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SOX10 is a high-mobility-group transcription factor that plays a critical role in the development of neural crest-derived
melanocytes. At E11.5, mouse embryos homozygous for the Sox10Dom mutation entirely lack neural crest-derived cells
xpressing the lineage marker KIT, MITF, or DCT. Moreover, neural crest cell cultures derived from homozygous embryos
o not give rise to pigmented cells. In contrast, in Sox10Dom heterozygous embryos, melanoblasts expressing KIT and MITF
do occur, albeit in reduced numbers, and pigmented cells eventually develop in nearly normal numbers both in culture and
in vivo. Intriguingly, however, Sox10Dom/1 melanoblasts transiently lack Dct expression both in culture and in vivo,
suggesting that during a critical developmental period SOX10 may serve as a transcriptional activator of Dct. Indeed, we
ound that SOX10 and DCT colocalized in early melanoblasts and that SOX10 is capable of transactivating the Dct promoter
n vitro. Our data suggest that during early melanoblast development SOX10 acts as a critical transactivator of Dct, that
MITF, on its own, is insufficient to stimulate Dct expression, and that delayed onset of Dct expression is not deleterious
to the melanocyte lineage.













The embryonic neural crest (NC) gives rise to multipo-
tent cells originating in the dorsal part of the neural tube
that are capable of differentiating into several lineages,
including the peripheral nervous system (PNS), glia, bone
and cartilage, adrenomedullary cells, and melanocytes of
the skin, hair, and inner ears. Melanoblasts (nondifferenti-
ated melanocyte precursors) appear at E10.5 and migrate
along a dorsolateral pathway, moving through the dermis to
the epidermis before taking up final positions in the hair
1 To whom correspondence should be addressed. Fax: (301) 402-
w2170. E-mail: bpavan@nhgri.nih.gov.
0012-1606/01 $35.00ollicles and epidermis, whereupon differentiation into
igment-producing melanocytes occurs.
Several mouse models have proven useful in studying
C-derived melanocyte development. For example, muta-
ions in MITF (microphthalmia) can result in the complete
ack of NC melanocytes due to early developmental loss
Nakayama et al., 1998; Opdecamp et al., 1997). PAX3
Splotch) mutations result in melanocyte deficiencies,
hile mutations in KIT (Dominant spotting) do not appar-
ntly affect commitment to the melanocyte lineage but
esult in a subsequent failure of melanoblasts to survive
ast early stages (Hou et al., 2000; Mackenzie et al., 1997;
ehrle-Haller and Weston, 1995). We have determined that
he hypopigmentary and enteric ganglion defects associated

















246 Potterf et al.tion within the SOX10 gene (Sox10Dom allele) (Southard-
mith et al., 1998). SOX10 is a member of the SRY (sex-
etermining factor)-like, HMG (high-mobility group) DNA
inding proteins (Wegner, 1999) that govern cell fate deci-
ions during embryonic development. It has a highly re-
tricted tissue distribution and plays a critical role in the
evelopment of NC derivatives (Herbarth et al., 1998;
FIG. 1. In situ hybridization for Dct expression in wild-type an
educed in Sox10Dom/1 embryos. Dct expression pattern revealed b
nd caudal trunk (C, G), and E13.5 head and caudal trunk (I, K). Sa
ead and caudal trunk (B, F), E12.5 pinna and caudal trunk region
learly apparent in Sox10Dom/1 embryos.uhlbrodt et al., 1998a; Southard-Smith et al., 1998). The
Copyright © 2001 by Academic Press. All rightSox10Dom mutation is a single base insertion downstream of
he DNA binding region that results in premature trunca-
ion of the C-terminal transactivation domain, with the
ddition of 99 extraneous amino acids (Herbarth et al.,
998; Southard-Smith et al., 1998). In Sox10Dom/Sox10Dom
embryos, NC development is severely disrupted (Southard-
Smith et al., 1998; Kapur, 1999). Sox10-expressing NC cells
x10Dom/1 E11.5–E13.5 mouse embryos. Dct expression is greatly
situ for Dct in wild-type E11.5 head and trunk (A, E), E12.5 pinna
robe was used in age-matched Sox10Dom/1 mutant embryos, E11.5
), and E13.5 head and caudal trunk (J, L). E13.5 Dct expression isd So
y in
me p
(D, Hform and are located at the dorsal portion of the neural tube.








































247Role of SOX10 in Melanoblast DevelopmentHowever, by E10.5, NC cells in rostral portions of the
embryo are greatly reduced; by E11.5, Sox10-expressing
cells are mostly gone, presumably due to apoptosis.
A complete lack of expression of the melanoblast marker
dopachrome tautomerase (Dct) (Steel et al., 1992) in E11.5
ox10Dom/Sox10Dom embryos (Southard-Smith et al., 1998)
ndicated that the melanocyte lineage is affected in Sox10
utants. In addition to Sox10, a number of mutations in
ther factors important to NC-derived melanocyte develop-
ent have been found. Like Sox10, Ednrb and Edn3 have
been implicated in melanocyte malformations resulting in
depigmented patches and sensorineural deafness in human
Waardenburg syndrome (WSIV) (Hofstra et al., 1996; Puffen-
erger et al., 1994). Mutations in transcription factors PAX3
WSI and III) and MITF (WSIIa) also result in the type of
berrant melanocyte development present in Waardenburg
yndrome (Read and Newton, 1997; Tachibana, 1999). The
olecular mechanisms that underlie the effects of these
utations on NC development are not fully understood.
ecent reports have shown that SOX10, either alone (Bon-
urand et al., 2000; Lee et al., 2000; Potterf et al., 2000;
erastegui et al., 2000) or in a synergistic relationship with
AX3 (Bondurand et al., 2000; Potterf et al., 2000), can
irectly regulate Mitf gene expression, leading to the devel-
pment of a model in which mutations in factors that affect
itf expression or function are causal agents of the depig-
ented patches and sensorineural deafness common to WS
atients. This suggests a transcriptional hierarchy headed
y SOX10 in which potential downstream targets such as
itf and others are dependent on functional SOX10 for
roper NC-derived melanocyte development. However, a
etailed analysis of melanoblast development in Sox10
utant embryos has not been performed, and the role of
OX10 in melanocyte development remains obscure.
In mammals, the role of MITF in the process of pigmen-
ation (melanogenesis) in differentiated melanocytes in-
olves regulating the expression of tyrosinase (albino locus)
Tanaka et al., 1990), a melanocyte-specific enzyme respon-
TABLE 1
Melanoblast/Melanocyte Marker Expression
in Neural Tube Cultures
Genotype
MITF DCT Melanin
2 day 14 day 2 day 14 day 2 day 14 day
ild type 4/4 5/5 4/4 5/5 0/4 5/5
ox10Dom/1 5/5 3/3 0/5 3/3 0/5 3/3
Sox10Dom/Dom 0/2 0/3 0/2 0/3 0/2 0/3
a Melanocyte differentiation was determined by identification of
elanin granules within cells and a typical dendritic morphology
s visualized using phase-contrast and bright-field microscopy.
b Values represent number of cultures positive for respective
arker per total number of cultures.ible for the initial, rate-limiting steps in melanin synthesis
Copyright © 2001 by Academic Press. All rightrom tyrosine (Hearing, 1993). Also important to this pro-
ess are two melanocyte-specific enzymes responsible forFIG. 2. Dct transgene expression in wild-type and Sox10Dom/1
mutant E10.5–E11.5 mouse embryos. No DCT production is appar-
ent in Sox10Dom/1 embryos. Dct transgene expression in otic
vesicle region of E10.5 wild-type embryo (A). Transgene expression
in mutant E10.5 embryo (B). Dct-driven transgene expression in
wild-type E11.0 (C, E) and E11.5 (G, I) head and trunk. Dct
transgene expression in Sox10Dom/1 E11.0 (D, F) and E11.5 (H, J)
ead and trunk regions. Note the variable levels of Dct transgene
expression in the eye. Since Sox10 is not expressed in the eye, it is
not expected to be linked to Dct expression.
s of reproduction in any form reserved.
td
248 Potterf et al.FIG. 3. E13.5 and E14.5 Dct transgene expression in wild-type and Sox10Dom/1 embryos in head, ear, trunk, and ventrum. Wild-type Dct
ransgene expression in E13.5 head and ear regions (A) and caudal trunk (C). Sox10Dom/1 Dct transgene expression in E13.5 head and ear
regions (B) and caudal trunk (D). Wild-type transgene expression in E14.5 head (E); higher magnification of head (G); ventrum (I); and higher
magnification of ventrum (K). Sox10Dom/1 Dct transgene expression in E14.5 head (F); higher magnification of head (H); ventrum (J); and
higher magnification of ventrum (L). Very few melanoblasts colonize the ventrum in mutant embryos at this stage of development.
Comparison of the number of DCT1 cells ( y axis) present directly above the eye in wild-type (filled circle and solid line) and Sox10Dom/1
embryos at different embryonic ages ( x axis) (M). The number of DCT1 cells was counted from three Dct-LacZ transgenic embryos for each
ata time point and is represented as the log of the mean values. Vertical bars represent the standard deviation of the mean.
































































249Role of SOX10 in Melanoblast Developmentnin: DCT (also known as TYRP2 or tyrosinase-related
protein 2; slaty locus) (Jackson et al., 1992; Tsukamoto
et al., 1992a), and TYRP1 (tyrosinase related protein 1; brown
locus) (Jackson, 1988; Shibahara et al., 1986). In the mouse,
dopachrome tautomerase activity associated with DCT
converts melanin biosynthetic intermediate dopachrome to
a less toxic and more stable melanin precursor, 5,6-
dihydroxyindole-2-carboxylic acid (DHICA), which serves
as a substrate for TYRP1 prior to incorporation into mela-
nin polymer (Jackson et al., 1992; Tsukamoto et al., 1992b).
ct is expressed early in E10.5 NC-derived melanoblasts
Steel et al., 1992), appearing several hours after Mitf and
it expression (Opdecamp et al., 1997), near the dorsal
idline, otic vesicle, and cranial regions, and has been a
seful marker for analyzing early melanocyte development
n mice. In vivo, utilization of DCT as a marker has been
articularly important in elucidating the roles of melano-
last genes Mitf (Hornyak et al., 2001; Nakayama et al.,
998; Opdecamp et al., 1997), Ednrb (Pavan and Tilghman,
994), Pax3 (Hornyak et al., 2001) and Kit (Mackenzie et al.,
997; Wehrle-Haller and Weston, 1995; Steel et al., 1992) in
elanocyte development. Accordingly, we have used these
arkers in the present study to analyze the roles of Sox10
n NC-derived melanoblast development, both in vivo and
n vitro. Our results suggest a critical function for SOX10 in
nitial melanoblast determination, showing that SOX10
ransiently regulates Dct expression during early melano-
yte development and that this transient regulation appears
o be independent of MITF function.
MATERIALS AND METHODS
Mice and Genotyping
Dominant megacolon (Sox10Dom/1) mice were obtained from the
ackson Laboratory and were maintained on a C57BL6/C3HeB/
eJLe-a/a background. Mitfmi/1 mice were maintained on a
57BL6/C3Fe-a/a background; Pax3Sp/1 mice were maintained on
a C57BL/6 background and both were obtained from the Jackson
Laboratory. KitW-lacZ/1 mice were obtained from J. J. Panthier
Bernex et al., 1996), and were maintained on a mixed C57BL6/
3H129Sv background. In KitW-lacZ/1 mice, the b-galactosidase
gene containing a nuclear localization signal was inserted into exon
1 of the Kit locus (Bernex et al., 1996). Therefore, resultant
b-galactosidase expression is indicative of KIT expression patterns
in heterozygous (or haploinsufficient) animals. Sox10Dom, Mitfmi,
nd Pax3Sp genotypes were determined by PCR (Southard-Smith et
l., 1998; Hornyak et al., 2001). LacZ genotyping with modifica-
ions was performed as previously described (Bernex et al., 1996).
IH guidelines for animal care were followed.
Transgenic Construction
The transgene was constructed by insertion of a b-galactosidase
oding sequence (LacZ) in front of approximately 3.5 kb of 59
pstream genomic regulatory sequence (Budd and Jackson, 1995)
nto the plasmid pPDct (Hornyak et al., 2000) to generate the
lasmid pPDct/lacZ (Hornyak et al., 2001). A linearized fragment
ontaining the Dct promoter and LacZ was obtained by digestion
Copyright © 2001 by Academic Press. All rightith NotI, and subsequently linear DNA was purified and used in
he construction of transgenic mice by standard techniques. Mice
n an FVB inbred background were used for transgenic construction
nd were maintained either by brother–sister matings or by mating
o FVB mice. Three founders were derived and found to have LacZ
xpression patterns comparable to endogenous Dct (Mackenzie et
l., 1997; Pavan and Tilghman, 1994; Steel et al., 1992). Line “I”
as chosen as having the most stable and reproducible Dct
romoter-driven LacZ expression pattern of DCT throughout sev-
ral generations. Previously published Dct transgenic mice
Hornyak et al., 2001; Mackenzie et al., 1997) have an extremely
trong ectopic dorsal root ganglion (DRG) staining as well as
taining in melanoblasts and have proven valuable for embryo
hole-mount analysis. Line “I” (this study), in contrast, had little
r no ectopic b-galactosidase in the DRG, with melanoblast stain-
ing still being readily detectable, thus establishing a system suit-
able for further study, particularly in neural tube explants and cell
culture.
Whole-Mount in Situ Hybridization of Mouse
Embryos and X-Gal Staining
Timed matings were set up to obtain staged mouse embryos,
designating the noon of plug formation as E0.5. Embryos were fixed
for 3 h to overnight in 4% paraformaldehyde/13 PBS. In situ
hybridizations were performed as previously described (Kos et al.,
1999). For detection of b-galactosidase activity in whole mounts,
mbryos were fixed in 1% formaldehyde/0.2% glutaraldehyde/
.02% NP40 in PBS for 30–90 min on ice and visualized by using
-gal as previously described (Bernex et al., 1996).
Neural Tube Culture, Antibodies, and
Immunohistochemistry
E9.5 murine embryos were obtained from either Sox10Dom/1 (X)
Sox10Dom/1 or Sox10Dom/1 (X) Dct-LacZI/Dct-LacZI matings. Neu-
ral tube explants were prepared as described previously (Hou et al.,
2000). Resultant neural tubes were placed in fibronectin-coated
wells containing DMEM, 10% FBS, and endothelin-3 (EDN3) (5 nM
final). Neural tube cultures were grown for 2, 5, or 14 days with
medium changes every other day prior to fixation. Cultures were
fixed in 4% paraformaldehyde/13 PBS (pH 7.5) for 25 min at RT,
followed by 0.1% Triton X-100 permeabilization for 5 min. For
double indirect immunolabeling (Table 1 only), NC cultures were
incubated with mouse primary antibodies against MITF (C5, Neo-
Markers, Inc) or rabbit antibodies against DCT (aPEP8, courtesy of
Vincent Hearing, NIH) for 60 min. The primary antibodies were
revealed with RITC-coupled goat anti-rabbit (Fab)2 and FITC-
oupled goat anti-mouse (Fab)2 (Molecular Probes). The samples
ere examined and photographed with a Reichert–Jung Polyvar
icroscope.
Polyclonal anti-SOX10 antibody was generated by using a highly
urified peptide corresponding in sequence to the SOX10 amino
cids 329–346 with an additional cysteine residue included at the
-terminal end (CDHRHPEEGSPMSDGNPEH-COOH). The anti-
ody was purified by immunoaffinity chromatography with the
urified peptide 329–346 immobilized on a SulfoLink column
Pierce) using its terminal cysteine. The purified antibody was
ested by immunofluorescence and by Western analysis of extracts
rom melan-c (positive control) and NIH3T3 (negative control) cells
R.M. and W.J.P., unpublished observations).Fixation and preparation of neural tube cultures for SOX10 and











250 Potterf et al.bgal double-labeling were carried out as described above. The cells
were incubated with diluted, purified anti-SOX10 antibody for 1 h
at 37°C. Anti-rabbit rhodamine-conjugated secondary antibody
(Molecular Probes) was diluted 1:400 and added to the cells for
incubation at 37°C for 1 h. Following removal of excess secondary
FIG. 4. KIT expression in E10.5–E11.5 embryos derived from
Sox10Dom/1; KitW-lacZ/1 matings. KIT expression in E10.5 otic
vesicle region in wild-type (A) and Sox10Dom/Sox10Dom (B) embryos.
Wild-type and Sox10Dom/Sox10Dom E11.5 whole embryo KIT expres-
sion (C, D). Head and ear KIT expression in wild-type (E) and
Sox10Dom/1 (F) E11.5 embryos. Rostrocaudal trunk KIT expression
in wild-type (G) and Sox10Dom/1 (H) E11.5 embryos. Arrows indi-
cate melanoblasts; arrowheads indicate trigeminal ganglion. Mela-
noblast and trigeminal ganglion KIT expression is absent by E11.5
in Sox10Dom/Sox10Dom mutant embryos. Melanoblasts are still
present on a Sox10Dom/1 background, although decreased in number.antibody, cells were incubated in mouse anti-bgal antibody (1:150)
Copyright © 2001 by Academic Press. All right(Promega), for 1 h at RT. Anti-mouse fluorescein-conjugated sec-
ondary antibody (Molecular Probes) was diluted 1:200 and added to
the cells for 1 h, RT.
Cell Line Culture, Plasmid Construction, and
Transient Transfections
Melan-a and melan-c (immortalized murine melanocyte cell
lines, pigmented and albino, respectively) were obtained from D.
Bennett (St. Georges Hospital, London) and were maintained in
RPMI 1640, supplemented with 5% FBS, 10 U/ml penicillin/
streptomycin, L-glutamine, sodium bicarbonate, sodium pyruvate,
and 100 nM phorbol 12-myristate 13-acetate and kept at 10% CO2.
IH3T3 and HeLa cells were maintained and grown in DMEM
upplemented with 10% FBS and 10 U/ml penicillin/streptomycin
nd were kept in 5% CO2. The cells were routinely passaged every
3–4 days and discarded after 15 passages. The murine SOX10 and
SOX10 deletion expression vector constructions have been de-
scribed previously (Potterf et al., 2000). The Dct reporter was
constructed by inserting the luciferase coding region from the
plasmid pGL2-Basic (Promega) into the Dct expression vector
pPDct (Hornyak et al., 2000) to generate plasmid pPdct/luc (hence-
forth referred to as pMuDct). The human Dct promoter was
generated by PCR (M. Furumura, unpublished observations) and
was placed upstream of firefly luciferase to generate plasmid
pHuDct. Transient transfections were conducted as published
previously (Potterf et al., 2000). Reporter assays were performed by
using the dual luciferase assay system (Promega) with Renilla
luciferase serving as an internal control. Luciferase activities were
determined by using a Lumat LB 9507 luminometer (EG&G
Berthold). All experiments were conducted at least three times on
different days using different batches of cells.
RESULTS
Absence of Melanoblast Marker Expression
in Mutant Neural Tube Cultures
To explore the functional role of SOX10 in NC-derived
melanocyte development, we analyzed the expression of
melanoblast markers in neural tube explants. E9.5 neural
tubes were cultured for 2 or 14 days (corresponding to E11.5
and 4 days postnatal, respectively) and examined for pig-
mentation and expression of MITF and DCT.
Pigmenting melanocytes are generally apparent by 6–10
days in neural tube cultures. In 14-day cultures, in explants
derived from Sox10Dom/Sox10Dom embryos (Table 1), pig-
entation was absent and no MITF or DCT expression was
bserved. In fact, Sox10Dom/Sox10Dom cultures grew to
maller diameters than wild-type and heterozygous cul-
ures, suggesting extensive defects in cell growth. Since all
ultures include EDN3, this experiment also showed that
DN3 could not complement the absence of functional
OX10 in vitro. Even in early (2-day) Sox10Dom/Sox10Dom
explants, MITF expression was absent. However in 2-day
wild-type and heterozygous cultures, NC cells expanded
from the neural tube and NC-derived melanoblasts ex-
pressed MITF (Table 1). This is consistent with our previous
observation that in vivo Sox10Dom/Sox10Dom embryos ini-
















251Role of SOX10 in Melanoblast Developmenttially form NC cells expressing Sox10, but fail to develop
further due to extensive apoptosis (Southard-Smith et al.,
1998). These data also support our hypothesis that muta-
tions in Sox10 disrupt Mitf expression, resulting in a failure
of melanocytes to develop (Lee et al., 2000; Potterf et al.,
2000). Together, these results are consistent with an es-
sential role for SOX10 early in NC-derived melanocyte
development.
Examination of melanocyte development in Sox10Dom/1
neural tube cultures yielded an unexpected finding. While
MITF1, DCT1, and pigmented cells were present in 14-day
Sox10Dom/1 neural tube cultures, DCT was not detected in
2-day Sox10Dom/1 neural tube cultures even though MITF
as present (Table 1). This result suggested that SOX10
ight have a selective role in Dct expression and that
the presence of MITF was not sufficient to induce Dct
production.
Transient Absence of DCT 1 Melanoblasts
in Sox10Dom/1 Embryos in Vivo
We had previously shown that Dct expression is absent in
NC-derived cells in E11.5 Sox10Dom/Sox10Dom embryos in
vivo (Southard-Smith et al., 1998) although it is present in
the retinal pigmented epithelium (RPE) and the telenceph-
alon. To further investigate our current in vitro observation
that DCT is also absent in 2-day Sox10Dom/1 cultures, we
xtended the analysis to in vivo studies. In situ hybridiza-
ion in E11.5 and E12.5 wild-type embryos revealed NC-
erived DCT1 cells in a characteristic distribution (Steel et
l., 1992) in the head and trunk regions, as well as pig-
ented neuroepithelium-derived cells in the eye (Figs. 1A,
C, 1E, 1G). Interestingly, and consistent with our neural
ube culture studies, DCT1 melanoblasts were almost
ntirely lacking in NC-derived cells of the head and trunk
egions in E11.5 and E12.5 Sox10Dom/1 mutant embryos
(Figs. 1B, 1D, 1F, 1H). Only a very few Dct-expressing cells
were present in the most caudal tail region of these two
stages. Neuroepithelial Dct expression in the eye, however,
was not affected. An absence of DCT1 melanoblasts was
unexpected given that Sox10Dom/1 mice are mostly pig-
mented with only ventral and occasional head spotting
(Southard-Smith et al., 1999). In the developing eye, Dct
xpression and pigmentation were not disrupted in
ox10Dom/1 mutants and an occasional DCT1 cell could be
seen around the otocyst or in the head of the embryo. Dct
expression in the eye is expected since Sox10 is not ex-
pressed in the RPE (Southard-Smith et al., 1999; Herbarth et
al., 1998) and no apparent abnormalities are seen in the eye
of Dominant megacolon mice. As we observed in neural
tube cultures, the absence of Dct expression in Sox10Dom/1
mutant embryos was transient, with a large increase in
Dct-positive melanoblast numbers appearing at E13.5 (Figs.
1J and 1L). The melanoblasts populate the Sox10Dom/1
embryos in a correct spatial manner, but are still signifi-
cantly reduced in number compared to wild type (Figs.
1I–1L). The transient absence of DCT1 melanoblasts in
Copyright © 2001 by Academic Press. All rightestricted portions of E11.5–E12.5 Sox10Dom/1 embryos
could be due either to a lack of melanoblasts at early stages
or to the absence of Dct expression in otherwise correctly
specified melanoblasts. Our results indicate the latter (vide
infra). Furthermore, the latter possibility is supported by
the observation that Sox10Dom/1 adult mice are pigmented,
FIG. 5. Dct transgene expression in E11.5 embryos heterozygous
or mutations in early melanoblast transcription factors. Dct trans-
gene expression in head and ear regions in Pax3Sp/1 (A), Mitfmi/1
(B), and Sox10Dom/1 (C) E11.5 mouse embryos. All three NC
mutants were mated to Dct-LacZI transgenic mice. Ey, eye. Ar-
rowheads point to clusters of DCT1 melanoblasts.indicating that functional melanocytes are present at birth.








































252 Potterf et al.Transient Lack of Dct-LacZ Transgene Expression
in Sox10Dom/1 Melanocyte Development
To further test whether there is a reduction of DCT
expression in Sox10Dom/1 melanoblasts, we engineered a
ransgenic line that expresses b-galactosidase from a 3.5-kb
inimal Dct promoter (see Materials and Methods). Xgal
taining in E10.5–E11.5 transgenic embryos exhibited a
attern similar to that of the endogenous Dct mRNA in situ
xpression, indicating that the DCT transgenic line repre-
ents an accurate measure of DCT production at these ages
Figs. 2A–2J). At E10.5, a typical melanoblast distribution
attern in wild-type embryos was found, but in age-
atched Sox10Dom/1 embryos, DCT expression pattern was
mostly absent in NC-derived melanoblasts and was re-
tained only in the optic cup (Figs. 2A and 2B). The lack of
b-galactosidase expression was also observed in rostral
regions of E11.0 and E11.5 Sox10Dom/1 embryos (Figs. 2D,
2F, 2H, 2J), with only few lightly staining cells present in
the rostral tail region and an occasional cell in the otocyst
or head of the embryo. Similar results were observed in a
second line of Dct-LacZ mice (Hornyak et al., 2001) (data
not shown). These data are consistent with the in situ
hybridizations (Figs. 1E and 1F), indicating that there is an
almost complete lack of DCT1 melanoblasts in restricted
portions of E10.5–E11.5 Sox10Dom/1 embryos. These data
also indicate that the information required to mediate the
induction of Dct expression in the usual temporal pattern
observed in embryos is contained within the minimal
promoter segment used to make the Dct-LacZI transgenic
mice (see transfection studies below).
Examination of b-galactosidase production at later ages
lso confirmed that the lack of DCT1 cells was transient.
ate E12.5 Sox10Dom/1; Dct-LacZI transgenic embryos
showed a few DCT-positive cells around the developing ear
and in the face, with greater numbers appearing in the trunk
region adjacent to the hindlimb (data not shown). These
cells were still very reduced in number and signal intensity
compared to what we observe in E12.5 Dct-LacZI trans-
enic embryos. However, E13.5 Sox10Dom/1; Dct-LacZI
utant embryos showed a large number of DCT-producing
elanoblasts that are in a correct spatial and temporal
istribution pattern (Figs. 3B and 3D), with b-galactosidase-
xpression patterns overlapping that of wild-type transgene.
he recovery of DCT-producing cells continued at E14.5
Figs. 3E–3H). At this age, nearly comparable numbers of
elanoblasts are detected in the caudal trunk region (not
hown), while only 65% recovery of DCT-producing cells is
bserved in the eye region and in the rostral posterolateral
runk (not shown). The most marked reduction of DCT-
xpressing melanoblasts occurs in the ventral region (Figs.
J and 3L), as few cells were observed to populate the
entrum in mutant embryos. Melanoblast entry to the
nvaginating hair follicle begins at this developmental stage
nd a lack of melanoblasts in the Sox10Dom/1 ventrum may
xplain the depigmented patch in this region in adult
ox10Dom/1 mice. Alternatively, melanoblasts may be
Copyright © 2001 by Academic Press. All rightpresent on the ventrum of E14.5 Sox10Dom/1 mice but are
representative of the endpoint of delayed Dct expression.
The delayed appearance of DCT1 melanoblasts suggests
that either melanoblasts newly recruited into the melano-
blast pathway have very rapidly repopulated the entire
mutant embryo or, more likely, SOX10 transiently controls
Dct expression in melanoblasts.
Consistent with a transient effect of SOX10 on Dct
expression, mice doubly heterozygous for Sox10Dom and
Dctslt-2J (slaty-2J, dark gray coat color) do not exhibit an
ltered coat color (data not shown) that might be expected if
he Sox10Dom mutation decreased the DCT level below the
threshold needed for normal pigmentation or melanocyte
survival. Also, aging Sox10Dom/1 mice do not appear to lose
elanocytes during successive hair cycles, suggesting that
elanoblast stem cell to melanocyte transitions are not
ensitive to reduced SOX10 function.
The Lack of Dct Expression Is Not Attributed
to a Lack of Melanoblasts
To address whether melanoblasts are present in E10.5–
E11.5 Sox10 mutant embryos, we followed the expression
f another early melanoblast marker, KIT, in embryos
erived from Sox10Dom/1; KitW-lacZ/1 matings. Analysis of
embryos from this mating utilized the endogenous Kit
promoter expression of LacZ and allowed us to determine
whether Kit-expressing melanoblasts are present on a
Sox10Dom background. Greatly reduced numbers of KIT1
cells were detected in E10.5 Sox10Dom/Sox10Dom embryos
compared to wild type (Figs. 4A and 4B). Consistent with
our hypothesis that there is total absence of melanoblasts in
early Sox10Dom/Sox10Dom embryos, no KIT1 melanoblasts
were observed in mutant E11.5 embryos (Fig. 4D). KIT was
detected in the trigeminal ganglion in wild-type and mutant
E10.5 embryos (Figs. 4A and 4B); however, soon after in
early E11.5 trigeminal ganglion, expression of KIT was not
detectable in Sox10Dom/Sox10Dom embryos (Fig. 4D), consis-
tent with a loss of peripheral nervous system derivatives as
a result of deficient NC development. In contrast, in E11.5
Sox10Dom/1 embryos, KIT1 melanoblasts could be observed
in a characteristic melanoblast distribution (Figs. 4E–4H).
Although the number of KIT1 melanoblasts was reduced to
27% of wild type in the mid-trunk region, these embryos
have comparable numbers of cells in eye region of the head,
and KIT1 cells are only reduced to 90% of wild type in the
caudal trunk area near the hindlimb (Figs. 4G and 4H).
Contrary to our Dct expression observations in Sox10Dom/1
embryos, many KIT1 melanoblasts were still present in a
proper spatiotemporal patterning, indicative of melanoblast
development at this time point. Therefore, large numbers of
KIT1 melanoblasts were still present on a Sox10Dom/1
ackground at E11.5. While we cannot rule out that the
estricted absence of DCT expression in melanoblasts of
ox10Dom/1 embryos is due to a developmental delay, taken
together with our observation that MITF1 melanoblasts are
present in 2-day Sox10Dom/1 neural tube cultures (Table 1)





































253Role of SOX10 in Melanoblast Developmentand KIT1 cells are present at 10.5 and 11.5 days in vivo, our
ata strongly suggest that the lack of DCT is due to
iminished induction of Dct within melanoblasts.
Embryonic DCT Production in Pax3, Mitf, and
Sox10 Heterozygous Spotting Mutants
We sought to determine whether the transient absence of
DCT1 cells is a phenomenon that is common in heterozy-
gous spotting mutants harboring mutations in transcription
factors required for early melanoblast development. The
transcription factors SOX10, PAX3, and MITF have been
proposed to have a hierarchical relationship in melanoblast
development (Bondurand et al., 2000; Potterf et al., 2000),
nd mutations in these transcription factors result in dis-
uption of NC-derived melanocyte development. Mice het-
rozygous for these mutations are almost totally pig-
ented, with variable white ventral spots (not shown). If
he absence of DCT1 cells was a common phenomenon in
ice heterozygous for spotting mutant genes, then Pax3
nd Mitf mutants may show a similar absence of DCT
etween E10.5 and E12.5. However, in E11.5 mutant em-
ryos, both Pax3Sp/1 and Mitfmi/1 embryos possess DCT1
elanoblasts around the eye and otocyst regions (Figs. 5A
nd 5B), as well as in the trunk (not shown). In contrast,
CT production at this age is almost completely absent in
ox10Dom/1 embryos (Fig. 5C), suggesting that the lack of
DCT may be unique to Sox10Dom mutants and strongly
upporting a critical role for SOX10 in transiently regulat-
ng Dct expression.
SOX10 and DCT Coexpression in Melanoblasts
To further investigate whether SOX10 function in mela-
nocyte development is intrinsic to melanoblasts, colocal-
ization of SOX10 and DCT was determined in order to
establish that these factors are expressed in the same cells
during the same stage of development. Neural tube explants
were obtained from Sox10Dom/1 X Dct-LacZI/Dct-LacZI
atings and transgene expression was tested for compara-
ility to Dct transgene expression in vivo. Indeed, 2-day
wild-type cultures corresponding to E11.5 embryos ex-
pressed b-galactosidase while Sox10Dom/1 cultures did not
Figs. 6A and 6B), recapitulating the phenotypes observed in
ivo (Figs. 2G and 2H). Wild type 2-day neural tube cultures
ave a large number of cells that express SOX10 in the
ucleus, with a small number of DCT-LacZ cells that show
OX10 and LacZ colocalization (Fig. 6C), indicating that
OX10 and DCT-LacZ are expressed together early in
ild-type melanoblasts. SOX10 and DCT-LacZ were also
oexpressed in both wild-type and Sox10Dom/1 5-day neural
ube cultures (Figs. 6D and 6E). The restoration of DCT-
acZ expression in 5-day mutant neural tube cultures
emporally correlates with E14.5 DCT expression patterns
n Sox10Dom/1 embryos (Figs. 3G and 3H). Because SOX10
and DCT-LacZ colocalize in Sox10Dom/1 melanoblasts at
this time (Fig. 6E), the restoration of DCT-LacZ production
Copyright © 2001 by Academic Press. All rightn mutant embryos does not completely depend on reduced
OX10 expression. Taken together, the results show that
OX10 and DCT are expressed together early in melanocyte
evelopment, presenting a framework for SOX10 regulation
f Dct in melanoblasts, and suggest that melanocyte devel-
opmental defects in Sox10 mutants are due to effects
intrinsic to melanoblasts.
In Vitro SOX10 Induction of Dct Expression
The ability of SOX10 to induce Dct expression was
determined by using in vitro transient transfection assays.
The minimal promoter fragment is capable of recapitulat-
ing the endogenous Dct expression (Fig. 1), both in vivo (Fig.
2) and in vitro (Figs. 6A and 6B). Using this fragment for in
vitro cotransfection studies, we found that SOX10 was able
to induce nearly 7-fold increases in Dct reporter activity in
murine melanocytes (Fig. 7A). Somewhat lesser induction
levels (5-fold) were observed by using a human Dct pro-
moter fragment (Fig. 7A). The murine Dct promoter was
also effectively activated by SOX10 in nonmelanocyte cell
lines HeLa and NIH3T3 (Fig. 7A). To examine the effects of
truncating mutations on SOX10 function, we used a SOX10
deletion construct (Potterf et al., 2000) that models human
and murine mutations that truncate the C-terminal trans-
activation domain (Pingault et al., 1998; Southard-Smith et
al., 1999). The SOX10 deletion construct completely failed
to activate Dct expression (Fig. 7A). In murine melanocytes,
the SOX10 deletion mutant acted in a dominant-negative
manner to completely inhibit the wild-type SOX10 induc-
tion of the Dct promoter (Fig. 7B). These data may explain
the mode of action by which the Sox10Dom mutation exerts
its effect on Dct expression and strongly support a role for
SOX10 in initiating control of Dct expression in early
melanoblast development.
DISCUSSION
SOX10 Is Essential for Neural Crest-Derived
Melanocyte Development
Genetic studies in mouse and human have implicated
SOX10 as possessing a critical function for mammalian NC
development. Using both in vivo and in vitro analyses of
melanoblast marker expression in the Dominant megaco-
lon mouse model for human Waardenburg syndrome IV, we
have determined that SOX10 is essential for NC-derived
melanocyte development. We speculate that SOX10 func-
tions early in melanocyte development, being necessary but
not sufficient for promoting the initial determination of NC
cells to melanoblasts. This early action of SOX10 is sup-
ported by several results. First, in mice that lack functional
SOX10 (as seen in Sox10Dom/Sox10Dom embryos), there is no
evidence of pigmentation or melanoblast marker expression
in vitro (DCT, MITF), or in vivo (DCT, KIT) by E11.5. The
absence of MITF1 cells in these mutants supports our
hypothesis that SOX10 directly regulates Mitf expression in

















254 Potterf et al.melanoblasts, and the resultant lack of MITF results in
failure of melanoblasts to develop (Potterf et al., 2000).
econd, in Sox10Dom/1 mice, the absence of most of the
DCT1 cells is transient, suggesting that the Sox10Dom
mutation exerts its effect on melanoblast development
until late E12.5–E13.5, with any differences in melanoblast
number after this stage attributable to earlier effects prior to
E12.5. Our results showing early involvement of SOX10 in
melanocyte development is similar to what has been pro-
posed for Ednrb (Shin et al., 1999). Using different methods,
hese authors showed that Ednrb is also required early in
elanocyte development, but not at later stages (Shin et al.,
999). More studies are needed to delineate further the
emporal requirements for SOX10 in proper melanocyte
evelopment and function.
Transient Absence of DCT1 Cells
in Sox10Dom/1 Embryos
Analysis of Dct expression in Sox10Dom/1 age-matched
mbryos revealed that DCT1 melanoblasts were almost
ompletely absent from E10.5 to E12.5. This was surprising
ince adult Sox10Dom/1 mice are almost completely pig-
mented. The early absence of DCT1 melanoblasts may be
unique to mice with mutations in Sox10 as we have shown
that PaxSp/1 and Mitfmi/1 heterozygous E11.5 embryos
FIG. 6. Dct transgenic expression in 2-day neural tube explants.
Immunohistochemical colocalization of SOX10 and Dct transgene
n 2-day and 5-day neural tube explants. Dct transgene expression
in wild-type (A) or Sox10Dom/1 (B) 2-day NC cultures. SOX10
(nuclear, red) colocalizes with DCT transgene (cytoplasmic, green)
in 2-day wild-type NC cultures (403 objective) (C). SOX10 (nuclear,
red) colocalizes with DCT transgene (cytoplasmic, green) in both
5-day wild-type (D) and Sox10Dom/1 (E) NC cultures (1003 objec-
ive). Scale bar, 10 mm.learly retain DCT1 melanoblasts in predicted regions.
Copyright © 2001 by Academic Press. All rightHow do we account for the appearance of melanoblasts in
regions previously lacking DCT1 cells? One possibility is
that DCT1 cells arise at 13.5 from proliferation of existing
DCT1 cells. Populations of late migrating melanoblasts
have been described in avian and zebrafish developmental
systems (Johnson et al., 1995; Milos et al., 1983; Sharma et
al., 1995). Consistent with these observations, recent find-
ings suggest the possibility of a second wave of late migrat-
ing melanoblasts in the mouse beginning at E15.5–E16.5
FIG. 7. Transient transfections of murine melanocytes with
SOX10 effector and Dct promoter/reporter constructs. Cotransfec-
tion with CMV-expressing SOX10 (SOX10) or CMV-expressing
SOX10 deletion (SOX10del) with Dct reporter (pMuDct or pHuDct)
(A). SOX10 or SOX10del was cotransfected with an equal amount
of pMuDct or pHuDct. Cotransfection with SOX10 resulted in 5- to
12-fold increases in luciferase reporter activity in three different
cell lines. Cotransfection with SOX10del failed to activate the Dct
romoter in any cell line. Dominant negative effect of C-terminal
OX10 mutant (B). Increasing amounts of SOX10del added to a
onstant amount of SOX10 abolished the ability of wild-type
OX10 to activate the Dct promoter. All samples contain 0.5 mg
MuDct. a, no effector; b, 0.5 mg SOX10; c–g, 0.1–0.5 mg SOX10del,plus 0.5 mg SOX10 for all; h, 0.5 mg SOX10del, no SOX10.
































255Role of SOX10 in Melanoblast Development(Jordan and Jackson, 2000). In patch and rump-white (Rw)
mice, a repopulation of melanoblasts occurred from a small
number of DCT1 cells located at the dorsal most portions
of the trunk (as in patch) or as a result of rostrocaudal
migration from regions of high density of melanoblasts to
low (Rw). While we cannot rule out a second wave of
migration accounting for the expansion of DCT1 cell
umbers, the melanoblast expansion reported in our study
iffers from the Jordan and Jackson model in several ways.
e observed in Sox10Dom/1 mutant embryos that both the
IT1 melanoblasts at E10.5–E11.5 and the rapidly appear-
ng DCT1 melanoblasts at E13.5 are present in their proper
ositions in the head, ear, and trunk and did not appear to
pread out or fill in from a very small population of survivor
lones along the dorsal midline. Although initially reduced
n number, melanoblasts populated the majority of the
mbryo in a correct spatial configuration by E14.5, much
arlier than proposed for the late wave of melanoblast
igration.
A second possibility to account for the appearance of
elanoblasts in regions lacking DCT1 cells is that mela-
oblasts are completely absent early on and then develop
rom a nonmelanoblast population of cells (for example,
chwann cells or their precursors). The reduction of KIT1
ells observed in Sox10Dom/1; KitW-lacZ/1 embryos could
represent the specific lack of a distinct KIT1DCT1 popu-
ation of melanoblast cells. The second population, consist-
ng of KIT1DCT2 cells (melanoblasts?), may not be af-
ected by the Sox10Dom mutation. This population would
hen become KIT1DCT1 around E13.5, and though re-
duced in number, these cells would proceed to develop into
melanocytes. This interpretation is less likely given the
comparison of KIT1 and DCT1 melanoblast numbers in
E11.5 embryos. Comparable numbers of KIT1 and DCT1
melanoblasts are found in the head and tail regions of
KitW-lacZ/1 and Dct-LacZ E11.5 embryos (both wild type at
the Sox10 locus). However, in Sox10Dom/1; KitW-lacZ/1 em-
bryos, there is only a 10% reduction in KIT1 melanoblasts
in the hindlimb and head regions whereas there is a .98%
reduction in DCT1 cells in these regions in Sox10Dom/1
embryos (Figs. 1E and 1F). If a KIT1DCT1 melanoblast
lineage were selectively lost in Sox10Dom/1 embryos, there
would be a far greater lack in KIT1 cells than was observed.
These data argue that, in Sox10Dom/1 embryos, melano-
lasts are present, but Dct is transiently reduced to unde-
ectable levels in most of these cells. In vitro, MITF1
elanoblasts were present in 2-day Sox10Dom/1 neural tube
ultures, and in vivo KIT1 melanoblasts were present in
he normal locations of E11.5 Sox10Dom/1; KitW-lacZ/1 em-
ryos. While the melanoblast numbers were reduced com-
ared to those of KitW-lacZ/1 embryos, the KIT1 melano-
blasts were in the correct spatiotemporal arrangement in
these embryos, suggesting that migration was not severely
delayed. The normal timing of expression of the MITF and
pigmentation melanocyte markers in vitro and KIT expression
in vivo suggests that the lack of DCT is not the result of an
overall developmental delay in melanocyte development. t
Copyright © 2001 by Academic Press. All rightSOX10 Is a Transcriptional Regulator of Dct
Consistent with the role of SOX10 as a transcriptional
regulator in NC derivatives (Kuhlbrodt et al., 1998a;
Peirano et al., 2000; Potterf et al., 2000), we have shown
that DCT-LacZ was colocalized with SOX10 in NC cul-
tures (Fig. 6C) and that SOX10 could induce Dct in vitro,
utilizing a Dct promoter fragment (Fig. 2) that exhibited
expression patterns nearly identical to endogenous Dct (Fig.
1). Wild-type SOX10 had the ability to significantly induce
both the murine and human Dct promoter whereas a
C-terminal deletion mutant completely failed to activate
them. Two recent reports support our findings of transcrip-
tional regulation of Dct by SOX10. One report described a
consensus HMG-box binding sequence within the human
Dct 59 flanking region that is needed for appropriate Dct
expression in melanoma cells (Amae et al., 2000). Further
analysis is needed to determine whether SOX10 can bind to
this region directly and if this region is needed for expres-
sion in vivo. A second report examined melanocyte markers
in the hindlimb of E12.5 embryos carrying a null allele of
Sox10 (Britsch et al., 2001). Homozygous mutants demon-
strated a reduction of KIT1 cells and absence of MITF and
DCT cells in this region. In heterozygotes, they noted
reduced number of DCT1 cells in E12.5 embryo and
demonstrated an in vitro induction from the murine Dct
promoter. This study suggested that haploinsufficiency can
account for some of the traits observed in Sox10 mutations.
MITF has been proposed as a possible transcriptional regu-
lator of Dct, suggesting that SOX10 influence over Dct may be
indirect. However, very little interaction between MITF and
the Dct promoter has been found, even though the Dct
promoter has cis elements similar to those contained within
the melanocyte-specific promoters for tyrosinase and TYRP-1
(Goding, 2000). These data, taken together with our demon-
strations that Mitfmi/1 E11.5 embryos produce DCT and that
ge-related Sox10Dom/1 neural tube cultures express MITF but
no DCT, strongly suggest that early transcriptional regulatory
control of Dct lies primarily with SOX10.
SOX10 alone cannot account for all Dct expression. Sox10
and Mitf mutants still exhibit Dct expression in the non-NC-
derived RPE, suggesting another transcriptional regulator(s) of
Dct in the RPE (Southard-Smith et al., 1998; Nakayama et al.,
1998; Opdecamp et al., 1997). Furthermore, the SOX10 con-
trol of Dct is transient since Sox10Dom/1 melanoblasts can
xpress Dct after E13.5. SOX10 is also not sufficient for Dct or
Mitf expression since other neural crest cells express SOX10
but do not form melanocytes. Additional studies are needed to
determine all necessary factors for initial expression of MITF
and for the maintenance of Dct expression during later stages
of melanocyte development.
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